| For: | Torres JL, Novo-Veleiro I, Manzanedo L, Alvela-Suárez L, Macías R, Laso FJ, Marcos M. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(36): 4104-4118 [PMID: 30271077 DOI: 10.3748/wjg.v24.i36.4104] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i36/4104.htm |
| Number | Citing Articles |
| 1 |
Komal Thapa, Ajmer Singh Grewal, Neha Kanojia, Lata Rani, Neelam Sharma, Sukhbir Singh. Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. Current Drug Discovery Technologies 2021; 18(3) doi: 10.2174/1570163817666200121143959
|
| 2 |
Agata Michalak, Małgorzata Guz, Joanna Kozicka, Marek Cybulski, Witold Jeleniewicz, Karolina Szczygieł, Ewa Tywanek, Halina Cichoż-Lach. microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis. Biomedicines 2024; 12(9) doi: 10.3390/biomedicines12092108
|
| 3 |
Ghedeir M. Alshammari, Wahidah H. Al‐Qahtani, Nora A. AlFaris, Nadiah S. Alzahrani, Mahmoud A. Alkhateeb, Mohammed Abdo Yahya. Quercetin prevents cadmium chloride‐induced hepatic steatosis and fibrosis by downregulating the transcription ofmiR‐21. BioFactors 2021; 47(3) doi: 10.1002/biof.1724
|
| 4 |
Alcohol induced impairment/abnormalities in brain: Role of MicroRNAs. NeuroToxicology 2021; 87 doi: 10.1016/j.neuro.2021.08.013
|
| 5 |
Laura Sabater, Luigi Locatelli, Fiona Oakley, Timothy Hardy, Jeremy French, Stuart M. Robinson, Gourab Sen, D. A. Mann, Jelena Mann. RNA sequencing reveals changes in the microRNAome of transdifferentiating hepatic stellate cells that are conserved between human and rat. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78776-3
|
| 6 |
Kyoko Oura, Asahiro Morishita, Tsutomu Masaki. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review. International Journal of Molecular Sciences 2020; 21(21) doi: 10.3390/ijms21218362
|
| 7 |
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Disease Markers 2020; 2020 doi: 10.1155/2020/8822859
|
| 8 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Konstantinos Papanikolopoulos, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Dimitris Matthaios, Michalis V. Karamouzis. An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. International Journal of Molecular Sciences 2023; 24(8) doi: 10.3390/ijms24087168
|
| 9 |
Mohamed Zaiou. Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders. Advances in Experimental Medicine and Biology 2019; 1134 doi: 10.1007/978-3-030-12668-1_10
|
| 10 |
Razieh Kazemzadeh, Maryam Kheirollahi, Seyed Ali Mard, Akram Ahangarpour, Feryal Savari. Regulatory, diagnostic, and therapeutic roles of microRNAs in chronic liver diseases. Acta Gastro Enterologica Belgica 2024; 87(3) doi: 10.51821/87.2.12965
|
| 11 |
Wenwen Wang, Xiuxiu Li, Ning Ding, Jun Teng, Shen Zhang, Qin Zhang, Hui Tang. miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4. BMC Genetics 2020; 21(1) doi: 10.1186/s12863-020-0836-7
|
| 12 |
Amanda Pasqualotto, Raquel Ayres, Larisse Longo, Diego Del Duca Lima, Diogo Losch de Oliveira, Mário Reis Alvares-da-Silva, Themis Reverbel da Silveira, Carolina Uribe-Cruz. Chronic exposure to ethanol alters the expression of miR-155, miR-122 and miR-217 in alcoholic liver disease in an adult zebrafish model. Biomarkers 2021; 26(2) doi: 10.1080/1354750X.2021.1874051
|
| 13 |
Meiyuan Zhang, Yan Tang, E. Tang, Weirong Lu. MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1. Biochemical and Biophysical Research Communications 2020; 524(3) doi: 10.1016/j.bbrc.2020.01.143
|
| 14 |
Meriem Ouni, Annette Schürmann. Epigenetic contribution to obesity. Mammalian Genome 2020; 31(5-6) doi: 10.1007/s00335-020-09835-3
|
| 15 |
Anik Banerjee, Anil K. Chokkalla, Julia J. Shi, Juneyoung Lee, Venugopal Reddy Venna, Raghu Vemuganti, Louise D. McCullough. Microarray Profiling Reveals Distinct Circulating miRNAs in Aged Male and Female Mice Subjected to Post-stroke Social Isolation. NeuroMolecular Medicine 2021; 23(2) doi: 10.1007/s12017-020-08622-2
|
| 16 |
Nawras W. Habash, Tejasav S. Sehrawat, Vijay H. Shah, Sheng Cao. Epigenetics of alcohol-related liver diseases. JHEP Reports 2022; 4(5) doi: 10.1016/j.jhepr.2022.100466
|
| 17 |
Pibao Li, Yanfen Yao, Yuezhen Ma, Yanbin Chen. MiR-30a-5p ameliorates LPS-induced inflammatory injury in human A549 cells and mice via targeting RUNX2. Innate Immunity 2021; 27(1) doi: 10.1177/1753425920971347
|
| 18 |
Luis M. Ruiz-Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, Sofía Madeline Osorio-Perez, Carolina Estrada-Meza, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.910733
|
| 19 |
D. I. Peregud, A. I. Korolkov, V. Y. Baronets, A. S. Lobacheva, M. L. Arkus, S. A. Igumnov, S. V. Pirozhkov, N. N. Terebilina. Contents of BDNF, miR-30a-5p AND miR-122 during Alcohol Withdrawal Syndrome. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2022; 16(4) doi: 10.1134/S1990750822040060
|
| 20 |
Sumita Thakur, Anjana Munshi, Prabhsimran Kaur. MicroRNA Crosstalk in Metabolic Disorders: The Dual Role of miR-122 and miR-34a in NAFLD and Type 2 Diabetes. Molecular Biotechnology 2026; doi: 10.1007/s12033-026-01576-z
|
| 21 |
Seong Lin Teoh, Srijit Das. MicroRNAs in Various Body Fluids and their Importance in Forensic Medicine. Mini-Reviews in Medicinal Chemistry 2022; 22(18) doi: 10.2174/1389557522666220303141558
|
| 22 |
Xiaoling Chen, Ting Lu, Ying Zheng, Zhiyong Lin, Chaoqi Liu, Ding Yuan, Chengfu Yuan. miR-155-5p promotes hepatic steatosis via PICALM-mediated autophagy in aging hepatocytes. Archives of Gerontology and Geriatrics 2024; 120 doi: 10.1016/j.archger.2024.105327
|
| 23 |
Victoria Shtratnikova, Vladimir Naumov, Vitaly Bezuglov, Anna Zheludkevich, Luidmila Smigulina, Yury Dikov, Tatiana Denisova, Alexander Suvorov, J. Richard Pilsner, Russ Hauser, Stephen A. Krawetz, Oleg Sergeyev. Optimization of small RNA extraction and comparative study of NGS library preparation from low count sperm samples. Systems Biology in Reproductive Medicine 2021; 67(3) doi: 10.1080/19396368.2021.1912851
|
| 24 |
Nasrin Motazedian, Negar Azarpira, Kimia Falamarzi, Mohsen Dehghani, Maryam Ataollahi, Elaheh Esfandiari, Mahintaj Dara, Ali Shekarforoush, Mehrab Sayadi, Razieh Toobafard. Expression of miR-34a in Children with Progressive Familial Intrahepatic Cholestasis: A Cross-Sectional Study Based on Shiraz Pediatric Liver Cirrhosis Cohort Study. Iranian Journal of Pediatrics 2024; 34(1) doi: 10.5812/ijp-142943
|
| 25 |
Kaifeng Chu, Jie Gu. microRNA-103a-3p promotes inflammation and fibrosis in nonalcoholic fatty liver disease by targeting HBP1. Immunopharmacology and Immunotoxicology 2022; 44(6) doi: 10.1080/08923973.2022.2102988
|
| 26 |
Rania Ahmed, Kenneth Blum, Panayotis K. Thanos. Epigenetic Effects of Psychoactive Drugs. Current Pharmaceutical Design 2023; 29(27) doi: 10.2174/1381612829666230706143026
|
| 27 |
Asahiro Morishita, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Hideki Kobara, Masafumi Ono, Takashi Himoto, Tsutomu Masaki. MicroRNAs and Nonalcoholic Steatohepatitis: A Review. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914482
|
| 28 |
Prabhudas Nelaturi, Sangeetha P Kademani, Krishna Sumanth Nallagangula, Sambandam Ravikumar. Role of MicroRNAs in Alcohol-Related Liver Disease. Alcoholism Treatment Quarterly 2024; 42(1) doi: 10.1080/07347324.2023.2256756
|
| 29 |
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar. The role of exosomal miRNA in nonalcoholic fatty liver disease. Journal of Cellular Physiology 2022; 237(4) doi: 10.1002/jcp.30699
|
| 30 |
Shujuan Sun, Wenqing Wang, Xuemei Hu, Cheng Zheng, Qi Xiang, Qingguo Yang, Jing Zhang, Zhi-Fa Shen, Zai-Sheng Wu. A sensing system constructed by combining a structure-switchable molecular beacon with nicking-enhanced rolling circle amplification for highly sensitive miRNA detection. The Analyst 2022; 147(9) doi: 10.1039/D1AN02218K
|
| 31 |
Kanza Saeed, Muhammad Farhan Jahangir Chughtai, Samreen Ahsan, Tariq Mehmood, Muhammad Zubair Khalid, Adnan Khaliq, Muhammad Zuhair, Waseem Khalid, Tawfiq Alsulami, Douglas Law, Emery Lenge Mukonzo.
Hepatoprotective Effect of a
Kalanchoe pinnata
–Based Beverage Against Carbon Tetrachloride– and Gentamicin-Induced Hepatotoxicity in Wistar Rats
. Journal of the American Nutrition Association 2025; 44(5) doi: 10.1080/27697061.2024.2442615
|
| 32 |
Raquel Rodríguez, Daniel Salete-Granado, Lourdes Hernández-Cosido, María Teresa Cabero Morán, Oscar Blanco, Nuria Matesanz, Vanessa Rueda-Cala, Fabiola Campo, María-Ángeles Pérez-Nieto, Carlos Gutiérrez Cerrajero, Edgar Bernardo, Ronald Macías, Guadalupe Sabio, Jorge-Luis Torres, Maura Rojas-Pirela, Miguel Marcos. miR-128-3p and miR-223-3p as Potential Biomarkers of Metabolic Dysfunction in Liver Tissue from Patients Undergoing Metabolic Bariatric Surgery. Obesity Surgery 2026; 36(4) doi: 10.1007/s11695-026-08499-3
|
| 33 |
Peng Huang, Biao Tu, Hui-jun Liao, Fei-zhou Huang, Zhen-zhou Li, Kuang-ye Zhu, Feng Dai, Huai-zheng Liu, Tian-yi Zhang, Chuan-zheng Sun. Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85421-0
|
| 34 |
D.I. Peregud, A.I. Korolkov, V.Y. Baronets, A.S. Lobacheva, M.L. Arkus, S.A. Igumnov, S.V. Pirozhkov, N.N. Terebilina. Contents of BDNF, miR-30a-5p and miR-122 during alcohol withdrawal syndrome. Biomeditsinskaya Khimiya 2022; 68(3) doi: 10.18097/pbmc20226803218
|
| 35 |
Debabrata Dash, Palak Kesharwani, Raj Kumar Koiri. Alterations in renal antioxidant and glycolytic enzymes associated with liver cirrhosis in rats and their modulation by biochemic tissue salts Natrum sulphuricum and Natrum phosphoricum. Gastroenterology & Endoscopy 2026; 4(3) doi: 10.1016/j.gande.2026.04.003
|
| 36 |
Jian-Wei Zhang, Kamran Ullah, Nauman Khan, Hai-Tao Pan. Comprehensive profiling of serum microRNAs in normal and non-alcoholic fatty liver disease (NAFLD) patients. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-87791-1
|
| 37 |
Caiyun Wu, Siyuan Xiang, Haitao Wang, Xiumin Zhang, Xueying Tian, Mingqian Tan, Wentao Su. Orally Deliverable Sequence-Targeted Fucoxanthin-Loaded Biomimetic Extracellular Vesicles for Alleviation of Nonalcoholic Fatty Liver Disease. ACS Applied Materials & Interfaces 2024; 16(8) doi: 10.1021/acsami.3c18029
|
| 38 |
Wenke Jonas, Annette Schürmann. Genetic and epigenetic factors determining NAFLD risk. Molecular Metabolism 2021; 50 doi: 10.1016/j.molmet.2020.101111
|
| 39 |
Sloan A. Lewis, Brianna Doratt, Suhas Sureshchandra, Tianyu Pan, Steven W. Gonzales, Weining Shen, Kathleen A. Grant, Ilhem Messaoudi. Profiling of extracellular vesicle‐bound miRNA to identify candidate biomarkers of chronic alcohol drinking in nonhuman primates. Alcoholism: Clinical and Experimental Research 2022; 46(2) doi: 10.1111/acer.14760
|
| 40 |
Laia Abad-Jordà, Ana Martínez-Alcocer, Sergi Guixé-Muntet, Nicholas J. Hunt, Lara J. Westwood, Juan José Lozano, Rocío Gallego-Durán, Victoria C. Cogger, Anabel Fernández-Iglesias, Jordi Gracia-Sancho. miR-27b-3p modulates liver sinusoidal endothelium dedifferentiation in chronic liver disease. Hepatology Communications 2025; 9(5) doi: 10.1097/HC9.0000000000000700
|
| 41 |
Yuji Hattori, Hiroya Yamada, Eiji Munetsuna, Ryosuke Fujii, Yoshitaka Ando, Mirai Yamazaki, Genki Mizuno, Yoshiki Tsuboi, Yuya Ishihara, Naohiro Ichino, Keiko Sugimoto, Keisuke Osakabe, Hiroaki Ishikawa, Koji Ohashi, Koji Suzuki. The Ratio of miR-122 to miR-20a (miR-122/miR-20a) Is a Useful Minimally Invasive Biomarker for Non-Alcoholic Fatty Liver Disease Detection. Genetic Testing and Molecular Biomarkers 2023; 27(8) doi: 10.1089/gtmb.2022.0155
|
| 42 |
Jorge Infante-Menéndez, Paula González-López, Raquel Huertas-Lárez, Almudena Gómez-Hernández, Óscar Escribano. Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease. Antioxidants 2023; 12(2) doi: 10.3390/antiox12020262
|
| 43 |
Chuhan Zhang, Yu Hang, Weimin Tang, Diptesh Sil, Heather C. Jensen-Smith, Robert G. Bennett, Benita L. McVicker, David Oupický. Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease. Pharmaceutics 2022; 14(3) doi: 10.3390/pharmaceutics14030669
|
| 44 |
Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3. Life Sciences 2021; 270 doi: 10.1016/j.lfs.2021.119071
|
| 45 |
Ting Ji, Weiguang Feng, Xiangcheng Zhang, Kui Zang, Xingxing Zhu, Futai Shang. HDAC inhibitors promote pancreatic stellate cell apoptosis and relieve pancreatic fibrosis by upregulating miR-15/16 in chronic pancreatitis. Human Cell 2020; 33(4) doi: 10.1007/s13577-020-00387-x
|
| 46 |
Shengliang Xin, Qiao Zhan, Xiaofan Chen, Jinghang Xu, Yanyan Yu. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01334-8
|
| 47 |
Ge Zeng, Hui Gao, Yanchao Jiang, Nazmul Huda, Themis Thoudam, Zhihong Yang, Jing Ma, Jian Sun, Suthat Liangpunsakul. Non-coding RNAs in alcohol-associated liver disease. Liver Research 2025; 9(2) doi: 10.1016/j.livres.2025.04.007
|
| 48 |
Szu-Yi Liu, I-Ting Tsai, Yin-Chou Hsu. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. International Journal of Molecular Sciences 2021; 22(10) doi: 10.3390/ijms22105170
|
| 49 |
Yao Liang, Na Hu, Xing Xia, Fangyan Li, Meihua Yang, Pinggui Lei, Peng Luo. Exploring Transcriptomic and MRI-Derived Parameters Correlations in NAFLD Fibrosis: Insights from a Rat Model. Digestive Diseases and Sciences 2026; 71(5) doi: 10.1007/s10620-025-09437-6
|
| 50 |
Jaspreet Sharma, Sergey A. Krupenko. Folate pathways mediating the effects of ethanol in tumorigenesis. Chemico-Biological Interactions 2020; 324 doi: 10.1016/j.cbi.2020.109091
|
| 51 |
Chandana Thimme Gowda, Mallikarjuna Siraganahalli Eshwaraiah, Jiaohong Wang, Youngyi Lim, Maria Lauda Tomasi, Nirmala Mavila, Komal Ramani. The AKAP12-PKA axis regulates lipid homeostasis during alcohol-associated liver disease. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02202-1
|
| 52 |
Giovanni Tarantino, Vincenzo Citro. What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02031-1
|
| 53 |
Camila Cristiane Pansa, Letícia Ramos Molica, Karen C. M. Moraes. Non-alcoholic fatty liver disease establishment and progression: genetics and epigenetics as relevant modulators of the pathology. Scandinavian Journal of Gastroenterology 2023; 58(5) doi: 10.1080/00365521.2022.2148835
|
| 54 |
Agnieszka Siomek-Gorecka, Anna Dlugosz, Damian Czarnecki. The Molecular Basis of Alcohol Use Disorder (AUD). Genetics, Epigenetics, and Nutrition in AUD: An Amazing Triangle. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22084262
|
| 55 |
Daniel Fuster, Xavier García-Calvo, Paola Zuluaga, Ferran Bolao, Robert Muga. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World Journal of Gastroenterology 2021; 27(23): 3223-3237 doi: 10.3748/wjg.v27.i23.3223
|
| 56 |
F. V. Hladkykh, I. V. Bielochkina, I. V. Koshurba, M. O. Chyzh. Modern hepatoprotection: a narrative review of existing approaches and prospects for the use of biotechnological drugs. Modern medical technology 2023; (3) doi: 10.34287/MMT.3(58).2023.9
|
| 57 |
Yiyi Hu, Xuetao Peng, Guoping Du, Zhiqiao Zhang, Yingji Zhai, Xingbo Xiong, Xiaoliang Luo. MicroRNA-122-5p Inhibition Improves Inflammation and Oxidative Stress Damage in Dietary-Induced Non-alcoholic Fatty Liver Disease Through Targeting FOXO3. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.803445
|
| 58 |
Jiali Zhang, Baochen Ma, Zixu Wang, Yaoxing Chen, Chengzhong Li, Yulan Dong. Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01292-0
|
| 59 |
Agata Wawrzkiewicz-Jałowiecka, Anna Lalik, Graça Soveral. Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue. International Journal of Molecular Sciences 2021; 22(10) doi: 10.3390/ijms22105226
|
| 60 |
Wiramon Rungratanawanich, Jacob W. Ballway, Xin Wang, Kyoung-Jae Won, James P. Hardwick, Byoung-Joon Song. Post-translational modifications of histone and non-histone proteins in epigenetic regulation and translational applications in alcohol-associated liver disease: Challenges and research opportunities. Pharmacology & Therapeutics 2023; 251 doi: 10.1016/j.pharmthera.2023.108547
|
| 61 |
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Marina Cipullo, Annachiara Coppola, Chiara Tammaro, Giuseppe Scafuro, Patrizia Iodice, Alessandro Federico. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers 2023; 15(21) doi: 10.3390/cancers15215178
|
| 62 |
Faye Chleilat, Alana Schick, Julie M. Deleemans, Raylene A. Reimer. Paternal Methyl Donor Supplementation in Rats Improves Fertility, Physiological Outcomes, Gut Microbial Signatures and Epigenetic Markers Altered by High Fat/High Sucrose Diet. International Journal of Molecular Sciences 2021; 22(2) doi: 10.3390/ijms22020689
|
| 63 |
Yifan Hu, Bernd Schnabl, Peter Stärkel. Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease. Cells 2025; 14(3) doi: 10.3390/cells14030207
|
| 64 |
Mahintaj Dara, Negar Azarpira, Nasrin Motazedian, Mahdokht Hossein-Aghdaie, Seyed-Mohsen Dehghani, Bita Geramizadeh, Elaheh Esfandiari. Differential Expression of MiR-21 and MiR-19 in Biliary Atresia: Diagnostic Potential and Therapeutic Implications. OBM Genetics 2025; 9(04) doi: 10.21926/obm.genet.2504319
|
| 65 |
Yunan Su, Chaowei Li, Weifeng Liu, Yibin Liu, Liangyi Li, Qingshi Chen. Comprehensive analysis of differentially expressed miRNAs in mice with kidney injury induced by chronic intermittent hypoxia. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.918728
|
| 66 |
Lei-Jie Huang, Meng-Yu Wang, Feng-Zhi Xin, Rui-Xu Yang, Jing Zeng, Tian-Yi Ren, Jian-Gao Fan. Sodium butyrate ameliorates liver fibrosis in metabolic dysfunction-associated steatohepatitis rats via miR-155-5p/SOCS1/PDGF signaling pathway. Hepatobiliary & Pancreatic Diseases International 2025; 24(4) doi: 10.1016/j.hbpd.2025.04.006
|
| 67 |
Aleksander J. Nowak, Borna Relja. The Impact of Acute or Chronic Alcohol Intake on the NF-κB Signaling Pathway in Alcohol-Related Liver Disease. International Journal of Molecular Sciences 2020; 21(24) doi: 10.3390/ijms21249407
|
| 68 |
Xiaohong Li, Shengwen He, Jian Zhou, Xiaoli Yu, Lanhua Li, Yumei Liu, Wanwei Li. Cr (VI) induces abnormalities in glucose and lipid metabolism through ROS/Nrf2 signaling. Ecotoxicology and Environmental Safety 2021; 219 doi: 10.1016/j.ecoenv.2021.112320
|
| 69 |
Ashmit Mittal, Vibhuti R Jakhmola, Sukriti Baweja. Bioengineered extracellular vesicles: The path to precision medicine in liver diseases. Liver Research 2025; 9(1) doi: 10.1016/j.livres.2025.02.002
|
| 70 |
Liz Simon, Flavia M. Souza-Smith, Patricia E. Molina. Alcohol-Associated Tissue Injury: Current Views on Pathophysiological Mechanisms. Annual Review of Physiology 2022; 84(1) doi: 10.1146/annurev-physiol-060821-014008
|
| 71 |
Jiye Zhang, Wenling Mou, Shiru Chen, Zhenting Wu, Shujie Zhang, Ping Liu, Haobo Sun, Hang Zhou, Ying Liu. Regulation of HDL metabolism in alcohol-associated liver disease: the role of HIF-1α and miR-185 in SR-BI suppression. The American Journal of Drug and Alcohol Abuse 2025; 51(4) doi: 10.1080/00952990.2025.2506529
|
| 72 |
Yi Zhang, Yanhui Li, Yang Liu, Hongzhi Wang, Yingli Chen, Bing Zhang, Meiqi Song, Lei Song, Qinchao Ding, Jiannan Qiu, Mingjian Fan, Lihui Qu, Zhigang Wang. Alcoholic Setdb1 suppression promotes hepatosteatosis in mice by strengthening Plin2. Metabolism 2023; 146 doi: 10.1016/j.metabol.2023.155656
|
| 73 |
Ruizhe Ren, Siying Ren, Yihan Xu, Xiao Liang, Xiyang Wei. Non-coding RNA networks in metabolic dysfunction-associated steatotic liver disease: Mechanisms and therapeutic perspectives. Liver Research 2026; doi: 10.1016/j.livres.2026.05.002
|
| 74 |
Trenton Glaser, Leonardo Baiocchi, Tianhao Zhou, Heather Francis, Ilaria Lenci, Giuseppe Grassi, Lindsey Kennedy, Suthat Liangpunsakul, Shannon Glaser, Gianfranco Alpini, Fanyin Meng. Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path. Journal of Cellular and Molecular Medicine 2020; 24(11) doi: 10.1111/jcmm.15182
|
| 75 |
Diana Gabriela Iacob, Adelina Rosca, Simona Maria Ruta. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World Journal of Gastroenterology 2020; 26(11): 1113-1127 doi: 10.3748/wjg.v26.i11.1113
|
| 76 |
Tomoko Tadokoro, Asahiro Morishita, Tsutomu Masaki. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. International Journal of Molecular Sciences 2021; 22(15) doi: 10.3390/ijms22158139
|
| 77 |
Ting Zhang, Zhihong Yang, Praveen Kusumanchi, Sen Han, Suthat Liangpunsakul. MicroRNA in Regenerative Medicine. 2023; doi: 10.1016/B978-0-12-820719-2.00016-8
|
| 78 |
Neelanjana Sarkar, Arpan Saha, Shubhrajit Roy, Mainak Sengupta. Non-coding RNAs in Wilson’s Disease: Plausible drivers of hepatic symptom heterogeneity. Mutation Research - Reviews in Mutation Research 2025; 796 doi: 10.1016/j.mrrev.2025.108570
|
| 79 |
Saad Saffo, Albert Do. Clinical Phenotyping and the Application of Precision Medicine in MAFLD. Clinical Liver Disease 2022; 19(6) doi: 10.1002/cld.1199
|
| 80 |
Yujing Wang, Tao Wei, Wei Zhao, Zixuan Ren, Yan Wang, Yiding Zhou, Xun Song, Ruidong Zhou, Xiaochu Zhang, Dongliang Jiao. MicroRNA-181a Is Involved in Methamphetamine Addiction Through the ERAD Pathway. Frontiers in Molecular Neuroscience 2021; 14 doi: 10.3389/fnmol.2021.667725
|
| 81 |
Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. International Journal of Molecular Sciences 2022; 23(24) doi: 10.3390/ijms232416226
|
| 82 |
Juliette Schönberg, Jürgen Borlak. miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failures. Molecular and Cellular Biochemistry 2025; 480(4) doi: 10.1007/s11010-024-05129-3
|
| 83 |
Po-Shuan Huang, Chia-Jung Liao, Ya-Hui Huang, Chau-Ting Yeh, Cheng-Yi Chen, Hui-Chi Tang, Cheng-Chih Chang, Kwang-Huei Lin. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers 2021; 13(21) doi: 10.3390/cancers13215361
|
| 84 |
Xueying Wang, Cai Zhang, Rishun Li, Yan Qiu, Yanbo Ma, Shuai Wang, Yuanxiao Li, Shuai Guo, Chenxu Li. Down-regulation of miR-29 improves lipid metabolism in fatty liver of dairy cows. Animal Biotechnology 2024; 35(1) doi: 10.1080/10495398.2024.2396414
|
| 85 |
Alix Bruneau, Jana Hundertmark, Adrien Guillot, Frank Tacke. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725390
|
| 86 |
Jingyi Qiao, Hanwei Li, Chen Jinxiang, Yanmei Shi, Ning Li, Pingsheng Zhu, Sisen Zhang, Mingsan Miao. Mulberry fruit repairs alcoholic liver injury by modulating lipid metabolism and the expression of miR-155 and PPARα in rats. Functional & Integrative Genomics 2023; 23(3) doi: 10.1007/s10142-023-01131-y
|
| 87 |
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression. Pathology - Research and Practice 2023; 251 doi: 10.1016/j.prp.2023.154809
|
| 88 |
Ali Mahmoudi, Amin Jalili, Alexandra E. Butler, Seyed H. Aghaee-Bakhtiari, Tannaz Jamialahmadi, Amirhossein Sahebkar. Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets. Journal of Clinical and Experimental Hepatology 2024; 14(4) doi: 10.1016/j.jceh.2024.101365
|
| 89 |
Tonaye Hinton, David Karnak, Ming Tang, Ralph Jiang, Yi Luo, Philip Boonstra, Yilun Sun, Derek J. Nancarrow, Erin Sandford, Paramita Ray, Christopher Maurino, Martha Matuszak, Matthew J. Schipper, Michael D. Green, Gregory A. Yanik, Muneesh Tewari, Issam El Naqa, Caitlin A. Schonewolf, Randall Ten Haken, Shruti Jolly, Theodore S. Lawrence, Dipankar Ray. Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis. Translational Oncology 2022; 21 doi: 10.1016/j.tranon.2022.101428
|
| 90 |
Liana Gheorghe, Speranta Iacob. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; doi: 10.1007/978-3-031-33548-8_12
|
| 91 |
Tiantian Feng, Yifan Tao, Yue Yan, Siqi Lu, Yan Li, Xing Zhang, Jun Qiang. Transcriptional Inhibition of AGPAT2 Induces Abnormal Lipid Metabolism and Oxidative Stress in the Liver of Nile Tilapia Oreochromis niloticus. Antioxidants 2023; 12(3) doi: 10.3390/antiox12030700
|
| 92 |
Kun Xiao, Shengchao Ma, Long Xu, Ning Ding, Hui Zhang, Lin Xie, Lingbo Xu, Yun Jiao, Huiping Zhang, Yideng Jiang. Interaction between PSMD10 and GRP78 accelerates endoplasmic reticulum stress-mediated hepatic apoptosis induced by homocysteine. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00455-z
|
| 93 |
Gerard J. Nuovo, David Suster, Hamdy Awad, Jean-Jacques Michaille, Esmerina Tili. The histologic and molecular correlates of liver disease in fatal COVID-19 including with alcohol use disorder. Annals of Diagnostic Pathology 2022; 57 doi: 10.1016/j.anndiagpath.2021.151881
|
| 94 |
Sen Liu, Min Fan, Qiang Zheng, Shengwei Hao, Longjun Yang, Qingrong Xia, Congcong Qi, Jinfang Ge. MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets. Biomedicine & Pharmacotherapy 2022; 148 doi: 10.1016/j.biopha.2022.112681
|
| 95 |
Halla M. Ragab, Wafaa M. Ezzat, Eman Mahmoud Hassan, Nabila Abd El Maksoud, Mie Afify, Mohamed D.E. Abd El-Maksoud, Wafaa Abd Elaziz. Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease. Journal of Genetic Engineering and Biotechnology 2023; 21(1) doi: 10.1186/s43141-023-00467-z
|
| 96 |
Mingjing Liu, Ting Lu, Yuanling Bai, Xingyu Han, Wanyi Zhang, Lei Zhang, Shudan Chen, Chen Lin, Chaoqi Liu, Chengfu Yuan. The Critical Role of microRNA-21 in Non-alcoholic Fatty Liver Disease
Pathogenesis. Current Pharmaceutical Design 2023; 29(12) doi: 10.2174/1381612829666230320152215
|
| 97 |
Mo Chen, Wanglei Zhong, Weiqi Xu. Alcohol and the mechanisms of liver disease. Journal of Gastroenterology and Hepatology 2023; 38(8) doi: 10.1111/jgh.16282
|
| 98 |
Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases. Biomolecules 2024; 14(3) doi: 10.3390/biom14030277
|
| 99 |
Eric Braverman, Catherine Dennen, Mark Gold, Abdalla Bowirrat, Ashim Gupta, David Baron, A. Roy, David Smith, Jean Cadet, Kenneth Blum. Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”. International Journal of Environmental Research and Public Health 2022; 19(9) doi: 10.3390/ijerph19095480
|
| 100 |
Eun Kyeong Lee, Eun-Jeong Jeon, So-Hyeon Han, Eun Young Jang, Kyung Jin Jung. Validation of a Bead-Based Multiplex Assay for miRNA Quantification in Rat Liver Inflammation. ACS Omega 2026; doi: 10.1021/acsomega.5c09640
|
| 101 |
Marzieh Jamalidoust, Maryam Shafaati, Mehdi Kalani, Maryam Zare, Mazyar Ziyeayan. MicroRNA let-7b inhibits hepatitis C virus and induces apoptosis in human hepatoma cells. Molecular Biology Reports 2022; 49(2) doi: 10.1007/s11033-021-06955-0
|